Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  F. Gage,et al.  Role of α-Synuclein in Adult Neurogenesis and Neuronal Maturation in the Dentate Gyrus , 2012, The Journal of Neuroscience.

[3]  Subhojit Roy,et al.  α-Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis , 2012, The Journal of Neuroscience.

[4]  Richard Wade-Martins,et al.  Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family , 2011, The Journal of Neuroscience.

[5]  Y. Liu,et al.  Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation , 2011, PloS one.

[6]  S. Chandra,et al.  αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction , 2010, Proceedings of the National Academy of Sciences.

[7]  T. Südhof,et al.  α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.

[8]  B. Ghetti,et al.  SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. , 2010, Brain : a journal of neurology.

[9]  B. Davletov,et al.  α‐Synuclein sequesters arachidonic acid to modulate SNARE‐mediated exocytosis , 2010, EMBO reports.

[10]  Jing Liu,et al.  Expression and Subcellular Location of Alpha-Synuclein During Mouse-Embryonic Development , 2010, Cellular and Molecular Neurobiology.

[11]  Shin-ichi Muramatsu,et al.  Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons , 2009, The Journal of Neuroscience.

[12]  Aj Lees,et al.  Parkinson's disease (vol 373, pg 2055, 2009) , 2009 .

[13]  Michael S Fanselow,et al.  Please Scroll down for Article Journal of Neurogenetics Behavioral Differences among C57bl/6 Substrains: Implications for Transgenic and Knockout Studies Behavioral Differences among C57bl/6 Substrains: Implications for Transgenic and Knockout Studies , 2022 .

[14]  R. Barker,et al.  The Effect of Truncated Human α-Synuclein (1–120) on Dopaminergic Cells in a Transgenic Mouse Model of Parkinson's Disease , 2007, Cell transplantation.

[15]  Bernardino Ghetti,et al.  Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human α-Synuclein(1–120): Implications for Lewy Body Disorders , 2006, The Journal of Neuroscience.

[16]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[17]  J. Winkler,et al.  Human Wild‐Type α‐Synuclein Impairs Neurogenesis , 2004 .

[18]  John Sharkey,et al.  Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice , 2004 .

[19]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[20]  L. Alberi,et al.  Midbrain Dopaminergic Neurons , 2003 .

[21]  C. Specht,et al.  Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice , 2001, BMC Neuroscience.

[22]  Wolfgang Wurst,et al.  Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes , 2001, The Journal of Neuroscience.

[23]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[24]  L. Olson,et al.  Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. , 1999, Experimental cell research.

[25]  Mark J. West,et al.  Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias , 1999, Trends in Neurosciences.

[26]  L. Thal,et al.  Expression Pattern of Synucleins (Non‐Aβ Component of Alzheimer's Disease Amyloid Precursor Protein/α‐Synuclein) During Murine Brain Development , 1998 .

[27]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[28]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[29]  David F. Clayton,et al.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.

[30]  M. Verrier,et al.  Different rates of age-related loss for four murine monoaminergic neuronal populations , 1991, Neurobiology of Aging.

[31]  J.L.O'L.,et al.  Chemical Pathology of the Nervous System (Proceedings of the Third International Neurochemical Symposium held at Strasbourg, 1958) , 1962, Neurology.

[32]  V. Buchman,et al.  Edinburgh Research Explorer Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice , 2010 .

[33]  T. Gasser.  Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects. , 2010, Progress in brain research.

[34]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[35]  V. Buchman,et al.  Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. , 2004, Journal of neurochemistry.

[36]  E. Masliah,et al.  Human wild-type alpha-synuclein impairs neurogenesis. , 2004, Journal of neuropathology and experimental neurology.

[37]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[38]  L. Alberi,et al.  Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. , 2003, Annals of the New York Academy of Sciences.

[39]  D. Sulzer,et al.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.

[40]  L. Thal,et al.  Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. , 1998, Journal of neurochemistry.

[41]  R A Crowther,et al.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[43]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.